Antispasticity drugs: Mechanisms of action

Annals of Neurology

Volumn 17, Issue 2, 1985, Pages 107-116

  Davidoff, Robert A ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; BACLOFEN; BENZODIAZEPINE; CARBAMAZEPINE; CHLORPROMAZINE; DANTROLENE; DIAZEPAM; GLYCINE; MOXISYLYTE; PHENOTHIAZINE; PHENYTOIN; PROGABIDE; PROPRANOLOL; RADIOISOTOPE;

4 AMINOBUTYRIC ACID H 3; BACLOFEN H 3; CENTRAL NERVOUS SYSTEM; CEREBRAL PALSY; DIAZEPAM H 3; DRUG MECHANISM; DRUG THERAPY; HUMAN; MUSCLE; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM; SHORT SURVEY; SPASTICITY; THERAPY;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMAL; ANTICONVULSANTS; BACLOFEN; BENZODIAZEPINES; CENTRAL NERVOUS SYSTEM; DANTROLENE; GAMMA-AMINOBUTYRIC ACID; GLYCINE; HUMAN; MUSCLE RELAXANTS, CENTRAL; MUSCLE SPASTICITY; NEUROTRANSMITTERS; PHENOTHIAZINES; RATS; RECEPTORS, NEUROTRANSMITTER; SPINAL CORD; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0021995178     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.410170202     Document Type: Article

References (151)

1. The effect of DOPA on the spinal cord. 1. Influences on transmission from primary afferents
2. The serotonin system of the spinal cord
3. Suppression by diphenylhydantion of afferent discharges arising in muscle spindles of the triceps surae of the car
4. Suppression of decerebrate rigidity of phenytoin and chlorpromazine
5. The neurophysiology of presynaptic inhibition
6. “Presynaptic” inhibition in spasticity and the effect of β‐(4‐chlorophenyl)GABA
7. Preliminary study of glycine administration in patients with spasticity
8. On the mode of action of SL 76002, a new GABA agonist
9. Pharmacological differentiation of muscle relaxants
10. Effects of an antispastic drug [β‐(4‐chlorophenyl)‐γ‐aminobutyric acid] on Renshaw cell activity
11. Classification of GABA receptors
12. A receptors
13. Heterogeneity of mammalian GABA receptors
14. Effects of dantrolene sodium on respiratory and other muscles and on respiratory parameters in the anesthetized cat
15. Neuropeptides in sensory neurons
16. An approach to the treatment of spasticity
17. A critical examination of the case for and against fusimotor involvement in disorders in muscle tone
18. The quadriceps stretch reflex in human spasticity
19. A phenothiazine derivative in the treatment of spasticity
20. The pharmacology of spasticity
21. 1 receptor binding
22. Phenytoin and chlorpromazine in the treatment of spasticity
23. Modulation of the tonic stretch reflex by monoamines
24. On the site of action of diazepam in spasticity in man
25. Mephenesin, methocarbamol, chlordiazepoxide and diazepam: actions on spinal reflexes and ventral root potentials
26. Two kinds of inhibition of cat spinal α‐motoneurones as differentiated pharmacologically
27. Central effects of β(p chlorophenyl)‐γ‐aminobutyric acid
28. Selective effects of (‐)baclofen on spinal synaptic transmission in the cat
29. Central actions of benzodiazepines
30. Alternative approaches to analgesia: baclofen as a model compound
31. Dilantin increases presynaptic inhibition
32. Pharmacology of spasticity
33. Studies of neurotransmitter actions (GABA, glycine, and convulsants)
34. Spinal inhibition
35. The effects of Lioresal on synaptic activity in the isolated spinal cord
36. Selective depression of synaptic excitation in cat spinal neurones by baclofen: an iontophoretic study
37. The actions of β‐phenyl‐GABA derivatives on neurones of the cat cerebral cortex
38. Approche de la Physiopathologie de la spasticite: reflexe de Hoffman et vibrations appliquées sur le tendon d'Achille
39. Preface: historical aspects of the relation of spasticity to movement
40. Sl 75 102 as a γ‐aminobutyric acid agonist: experiments on dorsal root ganglion neurones in vitro
41. B receptors on excitation‐secretion
42. Neurotransmitters decrease the calcium conductance activated by depolarization of embryonic chick sensory neurones
43. Presynaptic inhibition in the spinal cord
44. Excitation contraction uncoupling in skeletal muscle by dantrolene sodium
45. Studies on the mechanism of action of dantrolene sodium. A skeletal muscle relaxant
46. Effects of diphenylhydantoin on synaptic transmission in the cat spinal cord
47. Sites of action of a new muscle relaxant (baclofen, Lioresal, CIBA 34 647‐Ba)
48. Is Lioresal (baclofen) an antagonist of substance P
49. Action of baclofen on mammalian synaptic transmission
50. Electrophysiological characteristics of GABA‐receptor complexes
51. Benzodiazepines and central inhibitory mechanisms
52. The influence of DOPA on the static and dynamic fusimotor activity of the triceps surae of the spinal cat
53. An endogenous protein modulates the affinity of GABA and benzodiazepine receptors in rat brain
54. Possible involvement of GABA in the central action of benzodiazepines
55. Effect of dantrolene sodium on calcium movements in single muscle fibres
56. 3H‐substance P to rat brain membranes
57. The effects of baclofen on gamma motoneurones supplying gastrocnemius muscle in the rabbit
58. Review of European clinical trials with baclofen
59. Chlorpromazin und Spastizität: Eine experimentelle elektrophysiologische Untersuchung
60. Pharmacological studies on the prolonged depressant effects of baclofen on lumbar dorsal horn units in the cat
61. Effects of intraverously administered enantiomers of baclofen on functionally identified units in lumbar dorsal horn of the spinal cat
62. Phenytoin reduction of extensor tone and gamma motorneuron activity in the decerebrate cat
63. Effects of carbamazepine on muscle tone in the decerebrate cat
64. Effects of carbamazepine on muscle spindle discharges
65. Peptidergic neurones
66. Cenrtal muscle relaxant effects of diazepam
67. Changes in segmental reflexes following chronic spinal cord hemisection in the cat. 1. Increased monosynaptic and polysynaptic ventral root discharges
68. Changes in segmental reflexes following chronic spinal cord hemisection in the cat. 2. Conditioned monosynaptic test reflexes
69. The effects of a benzodiazepine on the hyperpolarizing and the depolarizing responses of hippocampal cells to GABA
70. Action of dantrolene sodium on single motor units of cat muscle in vivo
71. The effect of DOPA on the spinal cord. Reciprocal organization of pathways transmitting excitatory action to alpha motoneurones of flexors and extensors
72. Effects of diazepam on evoked electrospinogram and evoked electromyogram in man
73. 3H]aspartate from rat whole brain synaptosomes
74. A comparison of the effects of chlorpromazine and some related phenothiazines in reducing the rigidity of the decerebrate cat and in some other central actions
75. Dynamic motor capacity in spastic paresis and its relation to prime mover dysfunction, spastic reflexes and antagonist coactivation
76. Action of β‐(p‐chlorophenyl)‐γ‐aminobutyric acid (baclofen) on the isolated spinal cord of the frog
77. Symposium synopsis
78. Spasticity: the fable of a neurological demon and the emperor's new therapy
79. The action of dantrolene sodium on rat fast and slow muscle in vivo
80. The effect of dantrolene sodium on intrafusal muscle fibres in the rat soleus muscle
81. Analgesia produced by microinjection of baclofen and morphine at brain stem sites
82. Gamma‐aminobutyric acid (GABA) receptor stimulation. II. Specificity of progabide (SL 76002) and SL 75102 for the GABA receptor
83. Pharmacological profile of SL 76002, a new GABA‐mimetic drug
84. Benzodiazepines Specifically modulate GABA‐mediated postsynaptic inhibition in cultured mammalian neurones
85. Adrenergic influences on spasticity
86. Catecholamines and their actions in the spinal cord
87. Multiple benzodiazepine receptors: structures in the brain or structures in the mind? A critical review
88. Dimethothiazine in spasticity. A further attempt at pharmacological control
89. Some aspects of the pharmacology of decerebrate rigidity
90. Membrane actions of GABA in cultured central neurones
91. Benzodiazepine receptors and their ligands
92. THe clinical effect of the GABA‐agonist, progabide, on spasticity
93. On the therapeutic effect of SL 76002, a new GABA‐mimetic agent: Preliminary observations in neuropsychiatric disorders
94. Restitution of function and collateral sprouting in cat spinal cord: the partially hemisected animal
95. Correlation of changes in the GABA‐ergic system with the development of spasticity in paraplegic cats
96. Some comments on spasticity and rigidity
97. Immediate increase in Ia motoneuron synaptic transmission synaptic transmission caudal to spinal cord transection
98. Effect of diazepam and other central nervous system depressants on spinal reflexes in cats: a study of site of action
99. Spinal cord pharmacology of GABA and chemically related amino acids
100. Effects of flurazepam on amino acidevoked responses from the lobster muscle and the frog spinal cord
101. On noradrenaline receptor supersensitivity: correlation between nerve terminal densities and flexor reflexes various times after intracisternal 6‐hydroxydopamine
102. The biological activity of d‐ and l‐ baclofen (Lioresal)
103. Biochemical properties of GABA receptors
104. Substance P and excitatory transmitter of primary sensory neurons
105. The mode of action of the GABA derivative baclofen in human spasticity
106. Effect of dantrolene sodium on the discharge of primary spindle afferents during fusimotor stimulation
107. Is β‐(4‐chlorophenyl)‐GANA a specific antagonist of substance P on cerebral cortical neurones
108. Action of a GABA‐derivative on postsynaptic potentials and membrane properties of cats' spinal motoneurones
109. Effects of intravenous baclofen on dorsal horn neurons of spinal cats
110. Results of international clinical trials with Lioresal
111. Benzodiazepines enhance the bicucullinesensitive part of recurrent Renshaw inhibition in the cat spinal cord
112. The effect of diazepam on spinal cord activities: possible sites and mechanisms of action
113. Baclofen: effects on amino acid release and metabolism in slices of guinea pig cerbral cortex
114. Effects of chlorpromazine on the central nervous system of the cat. A possible neural basis for action
115. B receptors present on primary afferent terminals of the spinal cord
116. Actions and interactions of S‐glutamate in the spinal cord
117. Baclofen: physiological evidence for a presynaptic site of action in spinal cord cultures
118. Site of action of dantrolene in frog sartorius muscle
119. Spasticity and rigidity: An experimental study and review
120. Baclofen as an analgesic
121. The telationship of voluntary movement to spasticity in the upper motor neuron syndrome
122. Neurotransmitter candidates of somatosensory primary afferent fibers
123. Lack of effect of baclofen on substance P and somatostatin release from the spinal cord in vitro
124. On the involvement of GABA in the analgesia produced by baclofen, muscimol, and morphine
125. Action of diazepam on the spinal cord
126. Analysis of the action of CNS depressant drugs on somato‐somatic reflexes in the cat
127. Die Wirkung von Diazepam auf die präsynaptische Jemmung und andere Rückenmarksreflexe
128. Anti‐schizophrenic drugs‐membrane receptor sites of action
129. Human flexor spasms
130. The flexor reflex in spasticity
131. Distinction between the effects of barbiturates, benzodiazepines and phenytoin on responses to γ‐aminobutyric acid receptor activation and antagonism by bicuculline and picrotoxin
132. Enhancement of GABA binding by benzodiazepines and related anxiolytics
133. Diazepam enhancement of low affinity GABA binding to rat brain membranes
134. The effects of glycine replacement on canine spinal spasticity
135. Glycine therapy in 7 cases of spasticity. A pilot study
136. Diazepam and presynaptic inhibition
137. Diazepam and (‐)Pentobarbital: fluctuation analysis reveals different mechanisms for potentiation of gamma‐aminobytyric acei resposnes in cultured central neurons
138. Effect of glycine upon stretch reflex tension
139. Effect of baclofen on the γ‐motor activity in the rat
140. GABA and benzodiazepine receptors
141. Zur Pharmakologie des Antiepilepticums 5‐Carbabyl‐5H‐dibenzol[b, f]lazepin
142. Locus of action of centrally acting muscle relaxants, diazepam and tybamate
143. Renshaw cell activity in normal and spastic man
144. The effects of diazepam on presynaptic inhibition in patients with complete and incomplete spinal cord lesions
145. Thymoxamine and spasticity
146. Benzodiazepine binding and interactions with the GABA receptor complex in living cultures of rat cerebral cortex
147. Baclofen is antinociceptive in the spinal intrathecal space of animals
148. Glycine as a spinal cord neurotransmitter
149. Spasticity